ID   RBM15_HUMAN             Reviewed;         977 AA.
AC   Q96T37; A1A693; Q3ZB86; Q4V760; Q5D058; Q5T613; Q86VW9; Q96PE4; Q96SC5;
AC   Q96SC6; Q96SC9; Q96SD0; Q96T38; Q9BRA5; Q9H6R8; Q9H9Y0;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2003, sequence version 2.
DT   07-APR-2021, entry version 194.
DE   RecName: Full=RNA-binding protein 15 {ECO:0000305};
DE   AltName: Full=One-twenty two protein 1 {ECO:0000303|PubMed:16129689};
DE   AltName: Full=RNA-binding motif protein 15 {ECO:0000303|PubMed:11431691};
GN   Name=RBM15 {ECO:0000303|PubMed:11431691, ECO:0000312|HGNC:HGNC:14959};
GN   Synonyms=OTT {ECO:0000303|PubMed:16129689},
GN   OTT1 {ECO:0000303|PubMed:16129689};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND CHROMOSOMAL
RP   TRANSLOCATION WITH MKL1.
RX   PubMed=11431691; DOI=10.1038/90054;
RA   Ma Z., Morris S.W., Valentine V., Li M., Herbrick J.-A., Cui X., Bouman D.,
RA   Li Y., Mehta P.K., Nizetic D., Kaneko Y., Chan G.C.F., Chan L.C.,
RA   Squire J., Scherer S.W., Hitzler J.K.;
RT   "Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of
RT   acute megakaryoblastic leukemia.";
RL   Nat. Genet. 28:220-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, AND CHROMOSOMAL
RP   TRANSLOCATION WITH MKL1.
RX   PubMed=11344311; DOI=10.1073/pnas.101001498;
RA   Mercher T., Coniat M.B.-L., Monni R., Mauchauffe M., Khac F.N., Gressin L.,
RA   Mugneret F., Leblanc T., Dastugue N., Berger R., Bernard O.A.;
RT   "Involvement of a human gene related to the Drosophila spen gene in the
RT   recurrent t(1;22) translocation of acute megakaryocytic leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:5776-5779(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Hepatoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 21-977 (ISOFORM 1).
RC   TISSUE=Melanoma, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH EBV BSFL2/BMLF1 (MICROBIAL INFECTION).
RX   PubMed=16129689; DOI=10.1074/jbc.m501725200;
RA   Hiriart E., Gruffat H., Buisson M., Mikaelian I., Keppler S., Meresse P.,
RA   Mercher T., Bernard O.A., Sergeant A., Manet E.;
RT   "Interaction of the Epstein-Barr virus mRNA export factor EB2 with human
RT   Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links
RT   Spen proteins with splicing regulation and mRNA export.";
RL   J. Biol. Chem. 280:36935-36945(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-568; SER-622 AND SER-700, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, ALTERNATIVE INITIATION (ISOFORM 4),
RP   RNA-BINDING, AND INTERACTION WITH NXF1.
RX   PubMed=17001072; DOI=10.1074/jbc.m608745200;
RA   Lindtner S., Zolotukhin A.S., Uranishi H., Bear J., Kulkarni V.,
RA   Smulevitch S., Samiotaki M., Panayotou G., Felber B.K., Pavlakis G.N.;
RT   "RNA-binding motif protein 15 binds to the RNA transport element RTE and
RT   provides a direct link to the NXF1 export pathway.";
RL   J. Biol. Chem. 281:36915-36928(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-568; SER-670 AND SER-674, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257; SER-259; SER-292;
RP   SER-294; THR-568; SER-670; SER-674; SER-741 AND SER-935, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19786495; DOI=10.1093/nar/gkp782;
RA   Zolotukhin A.S., Uranishi H., Lindtner S., Bear J., Pavlakis G.N.,
RA   Felber B.K.;
RT   "Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA.";
RL   Nucleic Acids Res. 37:7151-7162(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670 AND SER-674, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-450, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-210; SER-257;
RP   SER-259; SER-294; SER-365; THR-568; SER-622; SER-670; SER-765 AND SER-935,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19586903; DOI=10.1074/jbc.m109.040113;
RA   Uranishi H., Zolotukhin A.S., Lindtner S., Warming S., Zhang G.M., Bear J.,
RA   Copeland N.G., Jenkins N.A., Pavlakis G.N., Felber B.K.;
RT   "The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the
RT   nuclear export receptor NXF1.";
RL   J. Biol. Chem. 284:26106-26116(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-294; THR-568;
RP   SER-741 AND SER-765, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   INTERACTION WITH SETD1B, AND MUTAGENESIS OF LYS-795; LYS-898 AND PHE-923.
RX   PubMed=22927943; DOI=10.1371/journal.pone.0042965;
RA   Lee J.H., Skalnik D.G.;
RT   "Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via
RT   a SPOC domain that is required for cytokine-independent proliferation.";
RL   PLoS ONE 7:E42965-E42965(2012).
RN   [24]
RP   IDENTIFICATION IN A MACOM-LIKE COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24100041; DOI=10.1074/jbc.m113.500397;
RA   Horiuchi K., Kawamura T., Iwanari H., Ohashi R., Naito M., Kodama T.,
RA   Hamakubo T.;
RT   "Identification of Wilms' tumor 1-associating protein complex and its role
RT   in alternative splicing and the cell cycle.";
RL   J. Biol. Chem. 288:33292-33302(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179; SER-208; SER-253;
RP   SER-257; SER-259; SER-292; SER-294; THR-568; SER-622; SER-656; SER-670;
RP   SER-674; SER-700; SER-741; SER-765; SER-767; SER-781 AND SER-935, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-257; SER-259;
RP   TYR-266; SER-292; SER-294; THR-568; SER-670; SER-674; SER-700 AND SER-741,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   FUNCTION, METHYLATION AT ARG-578, UBIQUITINATION, INTERACTION WITH SF3B1,
RP   AND MUTAGENESIS OF 574-ARG--ARG-578 AND ARG-578.
RX   PubMed=26575292; DOI=10.7554/elife.07938;
RA   Zhang L., Tran N.T., Su H., Wang R., Lu Y., Tang H., Aoyagi S., Guo A.,
RA   Khodadadi-Jamayran A., Zhou D., Qian K., Hricik T., Cote J., Han X.,
RA   Zhou W., Laha S., Abdel-Wahab O., Levine R.L., Raffel G., Liu Y., Chen D.,
RA   Li H., Townes T., Wang H., Deng H., Zheng Y.G., Leslie C., Luo M., Zhao X.;
RT   "Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15
RT   controls RNA splicing.";
RL   Elife 4:0-0(2015).
RN   [28]
RP   FUNCTION, RNA-BINDING, AND IDENTIFICATION IN THE WMM COMPLEX.
RX   PubMed=27602518; DOI=10.1038/nature19342;
RA   Patil D.P., Chen C.K., Pickering B.F., Chow A., Jackson C., Guttman M.,
RA   Jaffrey S.R.;
RT   "m(6)A RNA methylation promotes XIST-mediated transcriptional repression.";
RL   Nature 537:369-373(2016).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-406; LYS-420; LYS-445
RP   AND LYS-744, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: RNA-binding protein that acts as a key regulator of N6-
CC       methyladenosine (m6A) methylation of RNAs, thereby regulating different
CC       processes, such as hematopoietic cell homeostasis, alternative splicing
CC       of mRNAs and X chromosome inactivation mediated by Xist RNA
CC       (PubMed:27602518). Associated component of the WMM complex, a complex
CC       that mediates N6-methyladenosine (m6A) methylation of RNAs, a
CC       modification that plays a role in the efficiency of mRNA splicing and
CC       RNA processing (By similarity). Plays a key role in m6A methylation,
CC       possibly by binding target RNAs and recruiting the WMM complex
CC       (PubMed:27602518). Involved in random X inactivation mediated by Xist
CC       RNA: acts by binding Xist RNA and recruiting the WMM complex, which
CC       mediates m6A methylation, leading to target YTHDC1 reader on Xist RNA
CC       and promoting transcription repression activity of Xist
CC       (PubMed:27602518). Required for the development of multiple tissues,
CC       such as the maintenance of the homeostasis of long-term hematopoietic
CC       stem cells and for megakaryocyte (MK) and B-cell differentiation (By
CC       similarity). Regulates megakaryocyte differentiation by regulating
CC       alternative splicing of genes important for megakaryocyte
CC       differentiation; probably regulates alternative splicing via m6A
CC       regulation (PubMed:26575292). Required for placental vascular branching
CC       morphogenesis and embryonic development of the heart and spleen (By
CC       similarity). Acts as a regulator of thrombopoietin response in
CC       hematopoietic stem cells by regulating alternative splicing of MPL (By
CC       similarity). May also function as an mRNA export factor, stimulating
CC       export and expression of RTE-containing mRNAs which are present in many
CC       retrotransposons that require to be exported prior to splicing
CC       (PubMed:17001072, PubMed:19786495). High affinity binding of pre-mRNA
CC       to RBM15 may allow targeting of the mRNP to the export helicase DBP5 in
CC       a manner that is independent of splicing-mediated NXF1 deposition,
CC       resulting in export prior to splicing (PubMed:17001072,
CC       PubMed:19786495). May be implicated in HOX gene regulation
CC       (PubMed:11344311). {ECO:0000250|UniProtKB:Q0VBL3,
CC       ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495,
CC       ECO:0000269|PubMed:26575292, ECO:0000269|PubMed:27602518,
CC       ECO:0000305|PubMed:11344311}.
CC   -!- SUBUNIT: Component of the WMM complex, a N6-methyltransferase complex
CC       composed of a catalytic subcomplex, named MAC, and of an associated
CC       subcomplex, named MACOM (PubMed:27602518). The MAC subcomplex is
CC       composed of METTL3 and METTL14 (PubMed:27602518). The MACOM subcomplex
CC       is composed of WTAP, ZC3H13, CBLL1/HAKAI, VIRMA, and, in some cases of
CC       RBM15 (RBM15 or RBM15B) (PubMed:27602518). Also component of a MACOM-
CC       like complex, named WTAP complex, composed of WTAP, ZC3H13, CBLL1,
CC       VIRMA, RBM15, BCLAF1 and THRAP3 (PubMed:24100041). Interacts with RBPJ
CC       (By similarity). Interacts (via SPOC domain) with SETD1B
CC       (PubMed:22927943). Interacts with NXF1, the interaction is required to
CC       promote mRNA export (PubMed:17001072). Interacts with SF3B1
CC       (PubMed:26575292). {ECO:0000250|UniProtKB:Q0VBL3,
CC       ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:22927943,
CC       ECO:0000269|PubMed:24100041, ECO:0000269|PubMed:26575292,
CC       ECO:0000269|PubMed:27602518}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus
CC       BSFL2/BMLF1. {ECO:0000269|PubMed:16129689}.
CC   -!- INTERACTION:
CC       Q96T37; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-2514922, EBI-739580;
CC       Q96T37; Q9C0F1: CEP44; NbExp=3; IntAct=EBI-2514922, EBI-744115;
CC       Q96T37; Q92841: DDX17; NbExp=5; IntAct=EBI-2514922, EBI-746012;
CC       Q96T37; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-2514922, EBI-741037;
CC       Q96T37; Q8IVL1: NAV2; NbExp=3; IntAct=EBI-2514922, EBI-741200;
CC       Q96T37-3; Q8IZP0-5: ABI1; NbExp=3; IntAct=EBI-12041043, EBI-11743294;
CC       Q96T37-3; Q9H2G4: TSPYL2; NbExp=3; IntAct=EBI-12041043, EBI-947459;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:19586903,
CC       ECO:0000269|PubMed:24100041}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495,
CC       ECO:0000269|PubMed:24100041}. Nucleus envelope
CC       {ECO:0000269|PubMed:19586903}. Nucleus membrane
CC       {ECO:0000269|PubMed:19786495}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:19786495}. Note=Colocalizes at the nuclear pore
CC       with DBP5 and NXF1. {ECO:0000269|PubMed:19786495}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC       Name=1; Synonyms=RBM15s+ae;
CC         IsoId=Q96T37-1; Sequence=Displayed;
CC       Name=2; Synonyms=RBM15L;
CC         IsoId=Q96T37-2; Sequence=VSP_005811;
CC       Name=3; Synonyms=RBM15S;
CC         IsoId=Q96T37-3; Sequence=VSP_005812;
CC       Name=4;
CC         IsoId=Q96T37-4; Sequence=VSP_053877, VSP_005811;
CC   -!- PTM: Methylated at Arg-578 by PRMT1, leading to promote ubiquitination
CC       by CNOT4 and subsequent degradation by the proteasome.
CC       {ECO:0000269|PubMed:26575292}.
CC   -!- PTM: Ubiquitinated by CNOT4 following methylation at Arg-578 by PRMT1.
CC       {ECO:0000269|PubMed:26575292}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RBM15 may be a cause
CC       of acute megakaryoblastic leukemia. Translocation t(1;22)(p13;q13) with
CC       MKL1. Although both reciprocal fusion transcripts are detected in acute
CC       megakaryoblastic leukemia (AMKL, FAB-M7), the RBM15-MKL1 chimeric
CC       protein has all the putative functional domains encoded by each gene
CC       and is the candidate oncogene. {ECO:0000269|PubMed:11344311,
CC       ECO:0000269|PubMed:11431691}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative initiation of
CC       isoform 2. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the RRM Spen family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14088.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15185.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/OTTID175.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF368062; AAK54722.1; -; mRNA.
DR   EMBL; AF368063; AAK54723.1; -; mRNA.
DR   EMBL; AF368064; AAK54724.1; -; mRNA.
DR   EMBL; AF364035; AAK56920.1; ALT_TERM; mRNA.
DR   EMBL; AJ303089; CAC38828.1; ALT_TERM; mRNA.
DR   EMBL; AJ303090; CAC38829.1; ALT_TERM; mRNA.
DR   EMBL; AJ297259; CAC38861.1; -; Genomic_DNA.
DR   EMBL; AJ297259; CAC38862.1; -; Genomic_DNA.
DR   EMBL; AK022541; BAB14088.1; ALT_INIT; mRNA.
DR   EMBL; AK025596; BAB15185.1; ALT_INIT; mRNA.
DR   EMBL; AL355488; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56439.1; -; Genomic_DNA.
DR   EMBL; BC006397; AAH06397.2; -; mRNA.
DR   EMBL; BC047479; AAH47479.1; -; mRNA.
DR   EMBL; BC062316; AAH62316.1; -; mRNA.
DR   EMBL; BC098140; AAH98140.1; -; mRNA.
DR   EMBL; BC103493; AAI03494.1; -; mRNA.
DR   EMBL; BC103507; AAI03508.1; -; mRNA.
DR   EMBL; BK005915; DAA05818.1; -; mRNA.
DR   CCDS; CCDS59198.1; -. [Q96T37-3]
DR   CCDS; CCDS822.1; -. [Q96T37-1]
DR   RefSeq; NP_001188474.1; NM_001201545.1. [Q96T37-3]
DR   RefSeq; NP_073605.4; NM_022768.4. [Q96T37-1]
DR   SMR; Q96T37; -.
DR   BioGRID; 122293; 91.
DR   CORUM; Q96T37; -.
DR   IntAct; Q96T37; 35.
DR   MINT; Q96T37; -.
DR   STRING; 9606.ENSP00000358799; -.
DR   iPTMnet; Q96T37; -.
DR   PhosphoSitePlus; Q96T37; -.
DR   SwissPalm; Q96T37; -.
DR   BioMuta; RBM15; -.
DR   DMDM; 32363506; -.
DR   EPD; Q96T37; -.
DR   jPOST; Q96T37; -.
DR   MassIVE; Q96T37; -.
DR   MaxQB; Q96T37; -.
DR   PaxDb; Q96T37; -.
DR   PeptideAtlas; Q96T37; -.
DR   PRIDE; Q96T37; -.
DR   ProteomicsDB; 78180; -. [Q96T37-1]
DR   ProteomicsDB; 78181; -. [Q96T37-2]
DR   ProteomicsDB; 78182; -. [Q96T37-3]
DR   Antibodypedia; 4448; 126 antibodies.
DR   DNASU; 64783; -.
DR   Ensembl; ENST00000369784; ENSP00000358799; ENSG00000162775. [Q96T37-1]
DR   Ensembl; ENST00000487146; ENSP00000473552; ENSG00000162775. [Q96T37-3]
DR   Ensembl; ENST00000602849; ENSP00000473638; ENSG00000162775. [Q96T37-2]
DR   Ensembl; ENST00000618772; ENSP00000483133; ENSG00000162775. [Q96T37-1]
DR   Ensembl; ENST00000652342; ENSP00000498328; ENSG00000162775. [Q96T37-4]
DR   Ensembl; ENST00000652747; ENSP00000498634; ENSG00000162775. [Q96T37-3]
DR   GeneID; 64783; -.
DR   KEGG; hsa:64783; -.
DR   UCSC; uc001dzl.1; human. [Q96T37-1]
DR   CTD; 64783; -.
DR   DisGeNET; 64783; -.
DR   GeneCards; RBM15; -.
DR   HGNC; HGNC:14959; RBM15.
DR   HPA; ENSG00000162775; Tissue enhanced (bone).
DR   MalaCards; RBM15; -.
DR   MIM; 606077; gene.
DR   neXtProt; NX_Q96T37; -.
DR   OpenTargets; ENSG00000162775; -.
DR   Orphanet; 402023; Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13).
DR   PharmGKB; PA34264; -.
DR   VEuPathDB; HostDB:ENSG00000162775.14; -.
DR   eggNOG; KOG0112; Eukaryota.
DR   GeneTree; ENSGT00940000158161; -.
DR   InParanoid; Q96T37; -.
DR   OMA; DGWSLER; -.
DR   OrthoDB; 367857at2759; -.
DR   PhylomeDB; Q96T37; -.
DR   TreeFam; TF315637; -.
DR   PathwayCommons; Q96T37; -.
DR   SIGNOR; Q96T37; -.
DR   BioGRID-ORCS; 64783; 104 hits in 1005 CRISPR screens.
DR   ChiTaRS; RBM15; human.
DR   GeneWiki; RBM15; -.
DR   GenomeRNAi; 64783; -.
DR   Pharos; Q96T37; Tbio.
DR   PRO; PR:Q96T37; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q96T37; protein.
DR   Bgee; ENSG00000162775; Expressed in secondary oocyte and 244 other tissues.
DR   ExpressionAtlas; Q96T37; baseline and differential.
DR   Genevisible; Q96T37; HS.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0036396; C:RNA N6-methyladenosine methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0009048; P:dosage compensation by inactivation of X chromosome; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0060674; P:placenta blood vessel development; IEA:Ensembl.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; IEA:Ensembl.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0001510; P:RNA methylation; IDA:UniProtKB.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0038163; P:thrombopoietin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd12553; RRM1_RBM15; 1.
DR   CDD; cd12555; RRM2_RBM15; 1.
DR   CDD; cd12557; RRM3_RBM15; 1.
DR   Gene3D; 2.40.290.10; -; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR034470; RBM15_RRM1.
DR   InterPro; IPR034472; RBM15_RRM2.
DR   InterPro; IPR034473; RBM15_RRM3.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR016194; SPOC-like_C_dom_sf.
DR   InterPro; IPR012921; SPOC_C.
DR   InterPro; IPR010912; SPOC_met.
DR   Pfam; PF00076; RRM_1; 2.
DR   Pfam; PF07744; SPOC; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF100939; SSF100939; 1.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   PROSITE; PS50102; RRM; 3.
DR   PROSITE; PS50917; SPOC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Alternative splicing;
KW   Chromosomal rearrangement; Host-virus interaction; Isopeptide bond;
KW   Membrane; Methylation; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN           1..977
FT                   /note="RNA-binding protein 15"
FT                   /id="PRO_0000081777"
FT   DOMAIN          170..252
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          374..451
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          455..529
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          777..956
FT                   /note="SPOC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00249"
FT   COMPBIAS        60..166
FT                   /note="Gly/Ser-rich"
FT   COMPBIAS        616..732
FT                   /note="Arg-rich"
FT   SITE            954..955
FT                   /note="Breakpoint for translocation to form RBM15-MKL1"
FT                   /evidence="ECO:0000269|PubMed:11344311,
FT                   ECO:0000269|PubMed:11431691"
FT   MOD_RES         109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         210
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         266
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         450
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         568
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         578
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MOD_RES         578
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MOD_RES         622
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         656
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         670
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         674
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         700
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         741
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         765
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         767
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         781
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         935
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   CROSSLNK        246
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        406
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        420
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        445
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        744
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..44
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053877"
FT   VAR_SEQ         955..977
FT                   /note="GFGFQIGVRYENKKRENLALTLL -> AKLVEQRMKIWNSKL (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11431691,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_005812"
FT   VAR_SEQ         956..977
FT                   /note="FGFQIGVRYENKKRENLALTLL -> AS (in isoform 2 and
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11431691"
FT                   /id="VSP_005811"
FT   MUTAGEN         574..578
FT                   /note="RDRDR->KDKDK: Decreased, but not abolished
FT                   methylation by PRMT1."
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MUTAGEN         578
FT                   /note="R->K: Decreased methylation by PRMT1, leading to
FT                   decreased ubiquitination by CNOT4."
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MUTAGEN         795
FT                   /note="K->A: Disrupts interaction with SETD1B."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   MUTAGEN         898
FT                   /note="K->A: Disrupts interaction with SETD1B."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   MUTAGEN         923
FT                   /note="F->A: Disrupts interaction with SETD1B."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   CONFLICT        99
FT                   /note="H -> L (in Ref. 1; AAK54722/AAK54723/AAK54724 and 3;
FT                   BAB14088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="D -> N (in Ref. 6; AAI03494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        705
FT                   /note="R -> G (in Ref. 1; AAK54722/AAK54723/AAK54724 and 3;
FT                   BAB14088)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   977 AA;  107189 MW;  FB26AFE246E40282 CRC64;
     MRTAGRDPVP RRSPRWRRAV PLCETSAGRR VTQLRGDDLR RPATMKGKER SPVKAKRSRG
     GEDSTSRGER SKKLGGSGGS NGSSSGKTDS GGGSRRSLHL DKSSSRGGSR EYDTGGGSSS
     SRLHSYSSPS TKNSSGGGES RSSSRGGGGE SRSSGAASSA PGGGDGAEYK TLKISELGSQ
     LSDEAVEDGL FHEFKRFGDV SVKISHLSGS GSGDERVAFV NFRRPEDARA AKHARGRLVL
     YDRPLKIEAV YVSRRRSRSP LDKDTYPPSA SVVGASVGGH RHPPGGGGGQ RSLSPGGAAL
     GYRDYRLQQL ALGRLPPPPP PPLPRDLERE RDYPFYERVR PAYSLEPRVG AGAGAAPFRE
     VDEISPEDDQ RANRTLFLGN LDITVTESDL RRAFDRFGVI TEVDIKRPSR GQTSTYGFLK
     FENLDMSHRA KLAMSGKIII RNPIKIGYGK ATPTTRLWVG GLGPWVPLAA LAREFDRFGT
     IRTIDYRKGD SWAYIQYESL DAAHAAWTHM RGFPLGGPDR RLRVDFADTE HRYQQQYLQP
     LPLTHYELVT DAFGHRAPDP LRGARDRTPP LLYRDRDRDL YPDSDWVPPP PPVRERSTRT
     AATSVPAYEP LDSLDRRRDG WSLDRDRGDR DLPSSRDQPR KRRLPEESGG RHLDRSPESD
     RPRKRHCAPS PDRSPELSSS RDRYNSDNDR SSRLLLERPS PIRDRRGSLE KSQGDKRDRK
     NSASAERDRK HRTTAPTEGK SPLKKEDRSD GSAPSTSTAS SKLKSPSQKQ DGGTAPVASA
     SPKLCLAWQG MLLLKNSNFP SNMHLLQGDL QVASSLLVEG STGGKVAQLK ITQRLRLDQP
     KLDEVTRRIK VAGPNGYAIL LAVPGSSDSR SSSSSAASDT ATSTQRPLRN LVSYLKQKQA
     AGVISLPVGG NKDKENTGVL HAFPPCEFSQ QFLDSPAKAL AKSEEDYLVM IIVRGFGFQI
     GVRYENKKRE NLALTLL
//
